Last reviewed · How we verify
NCT03883438
Cor Adv Flap Plus Ac Derm Matrix in Thin Phenotype Multiple Recessions
NA trial testing Modified coronally advanced flap and acellular dermal matrix graft in Gingival Recession, Generalized in 22 participants. Completed in 15 February 2015.
1 January 2015
Quick facts
| Lead sponsor | Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 1 January 2014 |
| Primary completion | 1 January 2015 |
| Estimated completion | 15 February 2015 |
| Sites | 4 locations across Colombia, Turkey (Türkiye), Brazil, Azerbaijan |
Drugs / interventions tested
- Modified coronally advanced flap and acellular dermal matrix graft
Conditions studied
- Gingival Recession, Generalized — all drugs for Gingival Recession, Generalized →
Sponsor
Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors
Who can join
18 and older, any sex, with Gingival Recession, Generalized. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical evaluation of conventional and modified coronally advanced flaps combined with acellular dermal matrix graft
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03883438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gingival Recession, Generalized
Currently open trials in the same condition.
- NCT07158528 — Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Maxilla. · NA · recruiting
- NCT06409468 — NovoMatrix in Gingival Recession Coverage: Case Series · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03883438 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors
- Last refreshed: 27 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03883438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing